arrow
Z

Zhenming Fu

wuhan university
H指数:29
被引数:2,536

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Andamertinib in Advanced Non-Small-Cell Lung Cancer with EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results from the Phase 2 KANNON Study

安达曲尼布在EGFR外显子20插入的晚期非小细胞肺癌患者中的应用:铂类为基础的化疗或免疫治疗后的KANNON II期研究结果

2025-11-150
OAAI
A phase II study of Becotatug (JMT101) in combination with osimertinib (Osi) in patients (pts) with classical EGFR-mutated non-small cell lung cancer (NSCLC) (BOOSTER Study)

一项Becotatug(JMT101)联合奥希替尼(Osi)治疗经典EGFR突变非小细胞肺癌(NSCLC)患者的II期研究(BOOSTER研究)

2024-12-010
PRE
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer

抗EGFR抗体JMT101和奥希替尼治疗EGFR外显子20插入阳性非小细胞肺癌的1b期临床试验

2023-06-126
OAAI
Comparison of the performance of the GLIM criteria, PG-SGA and mPG-SGA in diagnosing malnutrition and predicting survival among lung cancer patients: A multicenter study
2023-06-019
PRE
Pan-Cancer Analysis of Microbiome Quantitative Trait Loci
2022-08-168
OA
Development and validation of a Modified Patient-Generated Subjective Global Assessment as a nutritional assessment tool in cancer patients

开发和验证改良的患者生成的主观全局评估作为癌症患者的营养评估工具

2021-12-0412
OAAI